Antonio
Pineda Lucena
Investigador Senior
Felipe
Prosper Cardoso
Consultor Médico
Publicaciones en las que colabora con Felipe Prosper Cardoso (11)
2024
-
An automated network-based tool to search for metabolic vulnerabilities in cancer
Nature Communications , Vol. 15, Núm. 1
-
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia
Nature Communications, Vol. 15, Núm. 1
-
G9a/DNMT1 co-targeting inhibits non-small cell lung cancer growth and reprograms tumor cells to respond to cancer-drugs through SCARA5 and AOX1
Cell Death and Disease, Vol. 15, Núm. 11
-
HDACi vorinostat protects muscle from degeneration after acute rotator cuff injury in mice
Bone and Joint Research, Vol. 12, Núm. 4, pp. 169-183
-
Modulation of tumor microenvironment by targeting histone acetylation in bladder cancer
Cell Death Discovery, Vol. 10, Núm. 1
2023
-
AG5 is a potent non-steroidal anti-inflammatory and immune regulator that preserves innate immunity
Biomedicine and Pharmacotherapy, Vol. 169
-
Identification and experimental validation of druggable epigenetic targets in hepatoblastoma
Journal of Hepatology, Vol. 79, Núm. 4, pp. 989-1005
2022
-
G9a inhibition by CM-272: Developing a novel anti-tumoral strategy for castration-resistant prostate cancer using 2D and 3D in vitro models
Biomedicine and Pharmacotherapy, Vol. 150
-
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming
Journal of Experimental and Clinical Cancer Research, Vol. 41, Núm. 1
2021
-
Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with in Vivo Efficacy in Multiple Myeloma
Journal of Medicinal Chemistry, Vol. 64, Núm. 6, pp. 3392-3426
2013
-
Multiple myeloma patients have a specific serum metabolomic profile that changes after achieving complete remission
Clinical Cancer Research, Vol. 19, Núm. 17, pp. 4770-4779